10-K Filing

ALIGNMENT HEALTHCARE, INC. CIK: 1832466 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0000950170-24-021154`
Period End Date	20231231
Filing Date	20240227
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	alhc-20231231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 75 Income Statement 63 Cash Flow Statement 132 Stockholders Equity 34

Balance Sheet 75 line items

Line Item	Tag	Value	Unit	Period
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$466.60M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$202.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$409.55M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable (less allowance for credit losses of $0 at December 31, 2023 and 2022)	`AccountsReceivableNetCurrent`	$119.75M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $0 at December 31, 2023 and 2022)	`AccountsReceivableNetCurrent`	$92.89M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$42.11M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$44.97M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Investments - current	`ShortTermInvestments`	$115.91M	USD	Point-in-time
Investments - current	`ShortTermInvestments`	-	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$544.55M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$483.54M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	188.95M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	187.28M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$37.17M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$51.90M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$9.96M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$5.83M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	187.28M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	188.95M	shares	Point-in-time
Goodwill	`Goodwill`	$34.83M	USD	Point-in-time
Goodwill	`Goodwill`	$34.81M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.25M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.48M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.41M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.04M	USD	Point-in-time
Total assets	`Assets`	$633.86M	USD	Point-in-time
Total assets	`Assets`	$591.88M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$205.40M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$170.13M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$23.51M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$32.29M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$34.11M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$27.54M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$229.96M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$263.02M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$160.90M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$161.81M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$8.97M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$3.70M	USD	Point-in-time
Total liabilities	`Liabilities`	$394.56M	USD	Point-in-time
Total liabilities	`Liabilities`	$433.81M	USD	Point-in-time
Commitments and Contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of December 31, 2023 and 2022, respectively; no shares issued and outstanding as of December 31, 2023 and 2022	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of December 31, 2023 and 2022, respectively; no shares issued and outstanding as of December 31, 2023 and 2022	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of December 31, 2023 and December 31, 2022; 188,951,643 and 187,280,015 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively	`CommonStockValue`	$187.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of December 31, 2023 and December 31, 2022; 188,951,643 and 187,280,015 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively	`CommonStockValue`	$189.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.04B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$970.18M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-732.24M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-880.26M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$156.95M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$238.13M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.18M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.12M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$306.06M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$633.86M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$591.88M	USD	Point-in-time

Income Statement 63 line items

Line Item	Tag	Value	Unit	Period
Earned premiums	`PremiumsEarnedNet`	$1.80B	USD	Annual
Earned premiums	`PremiumsEarnedNet`	$1.17B	USD	Annual
Earned premiums	`PremiumsEarnedNet`	$1.43B	USD	Annual
Other	`RevenueNotFromContractWithCustomer`	$2.61M	USD	Annual
Other	`RevenueNotFromContractWithCustomer`	$688.00K	USD	Annual
Other	`RevenueNotFromContractWithCustomer`	$22.70M	USD	Annual
Total revenues	`Revenues`	$1.82B	USD	Annual
Total revenues	`Revenues`	$1.43B	USD	Annual
Total revenues	`Revenues`	$1.17B	USD	Annual
Medical expenses	`MedicalExpenses`	$1.25B	USD	Annual
Medical expenses	`MedicalExpenses`	$1.04B	USD	Annual
Medical expenses	`MedicalExpenses`	$1.62B	USD	Annual
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$290.99M	USD	Annual
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$295.65M	USD	Annual
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$307.43M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$21.41M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$15.81M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$17.27M	USD	Annual
Total expenses	`OperatingExpenses`	$1.95B	USD	Annual
Total expenses	`OperatingExpenses`	$1.35B	USD	Annual
Total expenses	`OperatingExpenses`	$1.56B	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-178.07M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-127.82M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-128.64M	USD	Annual
Interest expense	`InterestExpense`	$18.29M	USD	Annual
Interest expense	`InterestExpense`	$17.44M	USD	Annual
Interest expense	`InterestExpense`	$21.23M	USD	Annual
Other expenses (income)	`OtherNonOperatingExpenseIncome`	$176.00K	USD	Annual
Other expenses (income)	`OtherNonOperatingExpenseIncome`	$-229.00K	USD	Annual
Other expenses (income)	`OtherNonOperatingExpenseIncome`	$-853.00K	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.20M	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Total other expenses	`OtherNonoperatingIncomeExpense`	$-20.66M	USD	Annual
Total other expenses	`OtherNonoperatingIncomeExpense`	$-17.21M	USD	Annual
Total other expenses	`OtherNonoperatingIncomeExpense`	$-20.38M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-195.29M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-148.19M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-149.30M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$-22.00K	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$339.00K	USD	Annual
Net loss	`ProfitLoss`	$-195.29M	USD	Annual
Net loss	`ProfitLoss`	$-149.64M	USD	Annual
Net loss	`ProfitLoss`	$-148.17M	USD	Annual
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-92.00K	USD	Annual
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	Annual
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-156.00K	USD	Annual
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-149.55M	USD	Annual
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-195.29M	USD	Annual
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-148.02M	USD	Annual
Total weighted-average common shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasic`	181.21M	shares	Annual
Total weighted-average common shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasic`	171.96M	shares	Annual
Total weighted-average common shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasic`	186.21M	shares	Annual
Total weighted-average common shares outstanding - diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockDiluted`	181.21M	shares	Annual
Total weighted-average common shares outstanding - diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockDiluted`	186.21M	shares	Annual
Total weighted-average common shares outstanding - diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockDiluted`	171.96M	shares	Annual
Net loss per share attributable to Alignment Healthcare, Inc. - basic	`EarningsPerShareBasic`	$-0.79	USD	Annual
Net loss per share attributable to Alignment Healthcare, Inc. - basic	`EarningsPerShareBasic`	$-1.14	USD	Annual
Net loss per share attributable to Alignment Healthcare, Inc. - basic	`EarningsPerShareBasic`	$-0.83	USD	Annual
Net loss per share attributable to Alignment Healthcare, Inc. - diluted	`EarningsPerShareDiluted`	$-0.79	USD	Annual
Net loss per share attributable to Alignment Healthcare, Inc. - diluted	`EarningsPerShareDiluted`	$-1.14	USD	Annual
Net loss per share attributable to Alignment Healthcare, Inc. - diluted	`EarningsPerShareDiluted`	$-0.83	USD	Annual

Cash Flow Statement 132 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-195.29M	USD	Annual
Net loss	`ProfitLoss`	$-149.64M	USD	Annual
Net loss	`ProfitLoss`	$-148.17M	USD	Annual
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$150.00K	USD	Annual
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$91.00K	USD	Annual
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$111.00K	USD	Annual
(Gain) loss on right of use assets	`GainLossOnRightOfUseAssets`	$289.00K	USD	Annual
(Gain) loss on right of use assets	`GainLossOnRightOfUseAssets`	-	USD	Annual
(Gain) loss on right of use assets	`GainLossOnRightOfUseAssets`	$-510.00K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$17.49M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$16.03M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$21.67M	USD	Annual
Amortization-debt issuance costs and investment discount	`AmortizationOfFinancingCostsAndDiscounts`	$1.85M	USD	Annual
Amortization-debt issuance costs and investment discount	`AmortizationOfFinancingCostsAndDiscounts`	$-3.66M	USD	Annual
Amortization-debt issuance costs and investment discount	`AmortizationOfFinancingCostsAndDiscounts`	$2.25M	USD	Annual
Amortization of payment-in-kind interest	`PaidInKindInterest`	$2.94M	USD	Annual
Amortization of payment-in-kind interest	`PaidInKindInterest`	$4.20M	USD	Annual
Amortization of payment-in-kind interest	`PaidInKindInterest`	-	USD	Annual
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-101.00K	USD	Annual
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	Annual
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	Annual
Equity-based compensation and common stock payments	`ShareBasedCompensationAndCommonStockPayments`	$110.60M	USD	Annual
Equity-based compensation and common stock payments	`ShareBasedCompensationAndCommonStockPayments`	$66.83M	USD	Annual
Equity-based compensation and common stock payments	`ShareBasedCompensationAndCommonStockPayments`	$81.72M	USD	Annual
Non-cash lease expense	`OperatingLeaseCost`	$2.81M	USD	Annual
Non-cash lease expense	`OperatingLeaseCost`	$2.73M	USD	Annual
Non-cash lease expense	`OperatingLeaseCost`	$2.32M	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.20M	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$26.95M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$34.38M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$17.61M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$14.36M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$10.34M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.86M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-644.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$142.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$86.00K	USD	Annual
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$12.51M	USD	Annual
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$44.25M	USD	Annual
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$35.26M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-6.35M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$13.74M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$437.00K	USD	Annual
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$3.61M	USD	Annual
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$-1.24M	USD	Annual
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$6.57M	USD	Annual
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-3.82M	USD	Annual
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-4.21M	USD	Annual
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-3.51M	USD	Annual
Payment-in-kind interest	`IncreaseDecreaseInDebtInstrumentPaymentInKindInterestOnPrincipalBalance`	$-14.12M	USD	Annual
Payment-in-kind interest	`IncreaseDecreaseInDebtInstrumentPaymentInKindInterestOnPrincipalBalance`	-	USD	Annual
Payment-in-kind interest	`IncreaseDecreaseInDebtInstrumentPaymentInKindInterestOnPrincipalBalance`	-	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-78.78M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-59.19M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-45.43M	USD	Annual
Purchase of business, net of cash received	`PaymentsToAcquireAssetsInvestingActivities`	$4.04M	USD	Annual
Purchase of business, net of cash received	`PaymentsToAcquireAssetsInvestingActivities`	-	USD	Annual
Purchase of business, net of cash received	`PaymentsToAcquireAssetsInvestingActivities`	-	USD	Annual
Asset acquisition, net of cash received	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$1.41M	USD	Annual
Asset acquisition, net of cash received	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Asset acquisition, net of cash received	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Purchase of investments	`PaymentsToAcquireInvestments`	$379.06M	USD	Annual
Purchase of investments	`PaymentsToAcquireInvestments`	$2.83M	USD	Annual
Purchase of investments	`PaymentsToAcquireInvestments`	$2.48M	USD	Annual
Sale of investments	`ProceedsFromSaleOfLongtermInvestments`	$2.42M	USD	Annual
Sale of investments	`ProceedsFromSaleOfLongtermInvestments`	$1.43M	USD	Annual
Sale of investments	`ProceedsFromSaleOfLongtermInvestments`	$267.79M	USD	Annual
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-18.36M	USD	Annual
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-35.99M	USD	Annual
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-23.77M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-28.22M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-147.26M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-20.82M	USD	Annual
Repurchase of noncontrolling interest	`PaymentsToMinorityShareholders`	$100.00K	USD	Annual
Repurchase of noncontrolling interest	`PaymentsToMinorityShareholders`	-	USD	Annual
Repurchase of noncontrolling interest	`PaymentsToMinorityShareholders`	-	USD	Annual
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$105.00K	USD	Annual
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$15.00K	USD	Annual
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$68.00K	USD	Annual
Equity repurchase	`PaymentsForRepurchaseOfEquity`	$1.47M	USD	Annual
Equity repurchase	`PaymentsForRepurchaseOfEquity`	-	USD	Annual
Equity repurchase	`PaymentsForRepurchaseOfEquity`	-	USD	Annual
Issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$165.00M	USD	Annual
Issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	Annual
Issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$5.20M	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Repayment of long-term debt	`RepaymentsOfLongTermDebt`	$143.18M	USD	Annual
Repayment of long-term debt	`RepaymentsOfLongTermDebt`	-	USD	Annual
Repayment of long-term debt	`RepaymentsOfLongTermDebt`	-	USD	Annual
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$390.60M	USD	Annual
Common stock issuance costs	`PaymentsOfStockIssuanceCosts`	$29.01M	USD	Annual
Common stock issuance costs	`PaymentsOfStockIssuanceCosts`	-	USD	Annual
Common stock issuance costs	`PaymentsOfStockIssuanceCosts`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$360.13M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$16.59M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$105.00K	USD	Annual
Net (decrease) increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-206.34M	USD	Annual
Net (decrease) increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$260.54M	USD	Annual
Net (decrease) increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-57.05M	USD	Annual
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.35M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.35M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$22.45M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$10.99M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$19.16M	USD	Annual
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$47.00K	USD	Annual
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$59.00K	USD	Annual
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$347.00K	USD	Annual
Purchase of business in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	-	USD	Annual
Purchase of business in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	-	USD	Annual
Purchase of business in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$505.00K	USD	Annual
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$466.60M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$202.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$409.55M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$1.75M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$2.05M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$1.75M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.35M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$306.06M	USD	Point-in-time
Beginning Balance, Shares	`CommonStockSharesIssued`	188.95M	shares	Point-in-time
Beginning Balance, Shares	`CommonStockSharesIssued`	187.28M	shares	Point-in-time
Net loss	`ProfitLoss`	$-195.29M	USD	Annual
Net loss	`ProfitLoss`	$-149.64M	USD	Annual
Net loss	`ProfitLoss`	$-148.17M	USD	Annual
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-149.55M	USD	Annual
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-195.29M	USD	Annual
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-148.02M	USD	Annual
Noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$105.00K	USD	Annual
Noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$1.17M	USD	Annual
Noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$15.00K	USD	Annual
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$1.04M	USD	Point-in-time
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$361.59M	USD	Annual
Issuance of common stock, net of issuance costs, Shares	`StockIssuedDuringPeriodSharesNewIssues`	9.20M	shares	Point-in-time
Issuance of common stock to third-party business partners	`StockIssuedDuringPeriodValueToTheThirdPartyBusinessProviders`	$6.48M	USD	Annual
Issuance of common stock to stock appreication rights holders	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$11.51M	USD	Annual
Issuance of common stock upon vesting of restricted stock units	`IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsValues`	$2.00K	USD	Annual
Forfeitures	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	-	USD	Annual
Forfeitures	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	$1.00K	USD	Annual
Forfeitures	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	-	USD	Annual
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$66.83M	USD	Annual
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$92.61M	USD	Annual
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$81.72M	USD	Annual
Equity repurchase	`StockRepurchasedDuringPeriodValue`	$1.47M	USD	Annual
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$306.06M	USD	Point-in-time
Ending Balance, Shares	`CommonStockSharesIssued`	188.95M	shares	Point-in-time
Ending Balance, Shares	`CommonStockSharesIssued`	187.28M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.